The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
Vicente Martinez-Vizcaino, Arthur E. Mesas, Iván Cavero-Redondo, Alicia Saz-Lara, Irene Sequí-Dominguez, Carlos Pascual-Morena, Celia Álvarez-Bueno
doi: https://doi.org/10.1101/2020.05.05.20091785
Vicente Martinez-Vizcaino
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
bUniversidad Autónoma de Chile, Facultad de Ciencias de la Salud, Talca, Chile
Arthur E. Mesas
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
cUniversidade Estadual de Londrina, Postgraduate Program in Public Health, Londrina, Paraná, Brazil
Iván Cavero-Redondo
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
dUniversidad Politécnica y Artística del Paraguay, Asunción, Paraguay
Alicia Saz-Lara
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
Irene Sequí-Dominguez
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
Carlos Pascual-Morena
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
Celia Álvarez-Bueno
aUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain
dUniversidad Politécnica y Artística del Paraguay, Asunción, Paraguay
Data Availability
All data come from public domain International Clinical Trials Registry Platform (WHO-ICTRP).
Posted May 14, 2020.
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
Vicente Martinez-Vizcaino, Arthur E. Mesas, Iván Cavero-Redondo, Alicia Saz-Lara, Irene Sequí-Dominguez, Carlos Pascual-Morena, Celia Álvarez-Bueno
medRxiv 2020.05.05.20091785; doi: https://doi.org/10.1101/2020.05.05.20091785
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
Vicente Martinez-Vizcaino, Arthur E. Mesas, Iván Cavero-Redondo, Alicia Saz-Lara, Irene Sequí-Dominguez, Carlos Pascual-Morena, Celia Álvarez-Bueno
medRxiv 2020.05.05.20091785; doi: https://doi.org/10.1101/2020.05.05.20091785
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (676)
- Anesthesia (182)
- Cardiovascular Medicine (2676)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12302)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4148)
- Geriatric Medicine (389)
- Health Economics (684)
- Health Informatics (2688)
- Health Policy (1009)
- Hematology (365)
- HIV/AIDS (859)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3930)
- Nursing (212)
- Nutrition (584)
- Oncology (2068)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (252)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1128)
- Primary Care Research (461)
- Public and Global Health (6572)
- Radiology and Imaging (1418)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)